The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 06, 2020
Filed:
Feb. 12, 2016
Applicant:
Memorial Sloan Kettering Cancer Center, New York, NY (US);
Inventors:
Scott W. Lowe, New York, NY (US);
Neal Rosen, New York, NY (US);
Eusebio Manchado-Robles, Basel, CH;
Susann Weissmueller, Basel, CH;
Assignee:
Memorial Sloan Kettering Cancer Center, New York, NY (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/519 (2006.01); A61K 31/506 (2006.01); A61K 31/496 (2006.01); C07D 487/04 (2006.01); C07D 471/04 (2006.01); A61K 31/5025 (2006.01); A61K 31/713 (2006.01); C07K 16/40 (2006.01); C12Q 1/6886 (2018.01); G01N 33/574 (2006.01);
U.S. Cl.
CPC ...
A61K 31/519 (2013.01); A61K 31/496 (2013.01); A61K 31/506 (2013.01); A61K 31/5025 (2013.01); A61K 31/713 (2013.01); C07D 471/04 (2013.01); C07D 487/04 (2013.01); C07K 16/40 (2013.01); C12Q 1/6886 (2013.01); C12Y 207/10001 (2013.01); C12Y 207/12002 (2013.01); G01N 33/57492 (2013.01); C12Q 2600/106 (2013.01); C12Q 2600/158 (2013.01); G01N 2333/71 (2013.01); G01N 2333/912 (2013.01); G01N 2440/14 (2013.01);
Abstract
The use of mitogen activated kinase inhibition therapy in combination with receptor tyrosine kinase therapy for the treatment of cancer is described.